On March 11th the California Attorney General’s office released the third draft of the regulations required to implement the California Consumer Privacy Act, lovingly known the world around as the CCPA. However unpopular versions 1 and 2 of the CCPA regulations might have been, at least there were […]
Peter McLaughlin is a partner in the firm's Privacy & Cybersecurity team and located in the Boston office.
When you are attentively (?) listening to the security announcements before a flight, they instruct each passenger to put their own oxygen mask on first, before helping others. The rationale is understandable in an emergency situation, and whether the health sector recognizes it or not, the cybersecurity of […]
On Monday, February 10th, the California Attorney General’s office released an updated version of the proposed regulations, addressing errors in the draft released before the weekend and extending the comment period to February 25 at 5pm PST. For those trying to keep track of what the eventual regulations […]
Secure your data. Really. If you do nothing else for the looming CCPA, secure the personal information you hold. It’s not as if this hasn’t been either a sensible or a required step in the past. But if you haven’t been paying rapt attention to the cacophony of […]
On October 10th California Attorney General Becerra released a set of proposed regulations as required by the California Consumer Privacy Act, which we have posted about here, here, and here. Although the draft rules do not incorporate the amendments passed by the legislature because they were not signed […]
Business Impact of the CCPA Amendments Since the California Consumer Privacy Act (“CCPA”) passed in June 2018, legislators have proposed and stakeholders have lobbied on more than a dozen amendments addressing various components of the CCPA. September 13 was the close of this legislative term and thus the […]
A recent issue of MIT’s Technology Review magazine is titled, “Look how far precision medicine has come.“ At least part of the premise is that personalized medicine or precision medicine is not perceived as having made the great strides promised nearly 20 years ago, when genome mapping was […]